NEWS
20211124
MediaFeatured Story on Heartseed was listed on Science Japan by Japan Science and Technology Agency (JST).
“Developing a next-generation therapy for severe heart failure using iPS cells”
2021810
PRHeartseed named “Ministry of Education, Culture, Sports, Science and Technology (MEXT) Award” at Academic Startups 2021
202172
OtherLAPiS Study, a Phase I/II Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With HF is posted on ClinicalTrials.gov
2021622
CongressKikuo Yasui, COO speaks at the International Society for Stem Cell Research (ISSCR) 2021, “Driving Change in Regenerative Medicine Through Global Partnerships: Organized by Novo Nordisk Stem Cell R&D”
2021615
CongressKeiichi Fukuda, CEO gave a presentation titled “Clinical Application of Human iPS Cell-Derived Ventricular Cardiomyocytes for Heart Failure Treatment” at Deep Tech in Asia: Stem Cell Innovations by SGInnovate.